UTICA, N.Y. — The U.S. Department of Defense (DOD) has awarded a $500,000 grant for an investigation ongoing at the Masonic Medical Research Institute (MMRI) in Utica.
The research directly addresses a critical need for military personnel who have survived catastrophic injuries, particularly those from blasts, MMRI said.
The money will help the work in developing methods to examine the health of vascularized composite allografts (VCA).
(Sponsored)
Latest Tax Scams and Schemes for Tax Filing Season
With the 2024 tax filing season upon us, now is a great time to remind taxpayers to stay vigilant and watch out for bogus tax strategies and schemes. Now more
In the Market to Build? Get Started in 4 Simple Steps
Finding the perfect home isn’t always easy, especially in our world today. The U.S. Housing Shortage has created an ongoing challenge for homebuyers across the nation, opening the door to
This will result in doctors having the ability to quickly determine whether graft rejection is occurring and alter the immunosuppression needed to keep the transplant viable, MMRI said.
VCAs are transplants made of skin, muscle, bones, and nerves, such as an arm or a face, to restore function and appearance.
Those surviving blasts would be candidates for VCAs, yet the risks associated with this “life-changing” therapeutic option “often outweigh the benefits,” as rejection of the graft could put the patient’s life at risk.
Jason McCarthy, associate professor of biomedical research and translational medicine at MMRI, is the principal investigator.
“Our goal is to develop technologies to facilitate routine examination of markers of rejection to catch episodes early, allowing for the modification of immunosuppressive therapies,” McCarthy said in the MMRI announcement. “Current gold standard diagnostics detect rejection too late. Using our technology, we envision in-home monitoring of graft health, enabling more widespread adoption of VCA transplantation.”
McCarthy — working alongside Carl Atkinson, Ph.D., from Northwestern University — combines expertise in the immune system with bioengineering to design these advanced imaging tools. The ultimate vision is to make these tools available in simple, user-friendly devices, MMRI said.
“We’re conducting groundbreaking research right here in the Mohawk Valley,” Maria Kontaridis, Ph.D., executive director, Gordon K. Moe professor and chair of biomedical research and translational medicine at MMRI, contended. “This funding will empower our talented scientists to help a part of the population who have sacrificed so much to keep our country safe—our dedicated soldiers and veterans. I am incredibly proud of Dr. McCarthy and his team for leading this vital project.”
